Introduction: Bacterial infections (BI) occur in 43%-59% of cirrhotic patients (CP) admitted to intensive care units (ICU) and are associated with higher morbidity, mortality, and frequency of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria. Objectives: To describe the characteristics of community-acquired (CA), healthcare-associated (HCA) and hospital-acquired (HA) infections in CP admitted to the ICU; to assess the frequency of acute kidney injury (AKI), hepatorenal syndrome (HRS), acute-on-chronic liver failure (ACLF), sepsis and mortality in CP with BI; and to evaluate the variables predictive of hospital mortality. Methods: Retrospective assessment of all infection episodes occurred in CP admitted in an ICU betw...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND & AIMS: Bacterial infections are a frequent and serious burden among patients with cirrho...
BACKGROUND & AIMS: Bacterial infections are a frequent and serious burden among patients with cirrho...
BACKGROUND & AIMS: Bacterial infections are a frequent and serious burden among patients with cirrho...
Background: In cirrhotic, bacterial infections are frequent and demands 25-40% of hospitalizations, ...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Contains fulltext : 138898.pdf (publisher's version ) (Closed access)BACKGROUND: I...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND & AIMS: Bacterial infections are a frequent and serious burden among patients with cirrho...
BACKGROUND & AIMS: Bacterial infections are a frequent and serious burden among patients with cirrho...
BACKGROUND & AIMS: Bacterial infections are a frequent and serious burden among patients with cirrho...
Background: In cirrhotic, bacterial infections are frequent and demands 25-40% of hospitalizations, ...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Infections are a leading cause of death in patients with advanced cirrhosis, but there are relativel...
Contains fulltext : 138898.pdf (publisher's version ) (Closed access)BACKGROUND: I...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...
BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there a...